Literature DB >> 8644746

Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.

S J Bredie1, L A Kiemeney, A F de Haan, P N Demacker, A F Stalenhoef.   

Abstract

Familial combined hyperlipidemia (FCH) is a heritable lipid disorder, in which dense low-density lipoprotein (LDL) subfraction profiles due to a predominance of small dense LDL particles are frequently observed. These small dense LDL particles are associated with cardiovascular disease. Using segregation analysis, we investigated to what extent these LDL subfraction profiles are genetically determined; also, the mode of inheritance was studied. Individual LDL subfraction profiles were determined by density gradient ultracentrifugation in 623 individuals of 40 well-defined Dutch FCH families. The individual LDL subfraction profile was defined as a quantitative trait by the continuous variable K, a reliable estimate of the relative contribution of each LDL subfraction to the overall profile. Variation in parameter K due to age, sex, and hormonal status was taken into account by introducing liability classes. Segregation analysis was performed by fitting a series of class D regressive models, implemented in the Statistical Analysis for Genetic Epidemiology (SAGE) program, after which genetic models were compared using log-likelihood ratio tests. Our data show that 60% of the variability of parameter K could be explained by lipid and lipoprotein levels and that a major autosomal locus, recessively inherited, with a population frequency of .42 +/- .07, and an additional polygenic component of .25 best explained the clustering of atherogenic dense LDL subfraction profiles in these FCH families. Therefore, dense LDL subfraction profiles, associated with elevated lipid levels, appear to have a genetic basis in FCH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644746      PMCID: PMC1914678     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  LDL physical and chemical properties in familial combined hyperlipidemia.

Authors:  J E Hokanson; R M Krauss; J J Albers; M A Austin; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

2.  Complex segregation analysis of LDL peak particle diameter.

Authors:  M A Austin; G P Jarvik; J E Hokanson; K Edwards
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

3.  Immunonephelometric assay of human apolipoprotein AI.

Authors:  M F Lopes-Virella; G Virella; G Evans; S B Malenkos; J A Colwell
Journal:  Clin Chem       Date:  1980-07       Impact factor: 8.327

4.  The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.

Authors:  M J Hoffer; S J Bredie; D I Boomsma; P W Reymer; J J Kastelein; P de Knijff; P N Demacker; A F Stalenhoef; L M Havekes; R R Frants
Journal:  Atherosclerosis       Date:  1996-01-26       Impact factor: 5.162

5.  Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.

Authors:  A H Kissebah; S Alfarsi; P W Adams
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694

Review 6.  Inheritance of plasma apolipoprotein B levels in families of patients undergoing coronary arteriography at an early age.

Authors:  J Coresh; T H Beaty; P O Kwiterovich
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

7.  Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.

Authors:  P Cullen; B Farren; J Scott; M Farrall
Journal:  Arterioscler Thromb       Date:  1994-08

8.  Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.

Authors:  S J Bredie; T W de Bruin; P N Demacker; J J Kastelein; A F Stalenhoef
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

9.  A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein.

Authors:  P N Demacker; A G Hijmans; H E Vos-Janssen; A van't Laar; A P Jansen
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

10.  Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

Authors:  J D Brunzell; J J Albers; A Chait; S M Grundy; E Groszek; G B McDonald
Journal:  J Lipid Res       Date:  1983-02       Impact factor: 5.922

View more
  11 in total

1.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia.

Authors:  M De Michele; A Iannuzzi; A Salvato; P Pauciullo; M Gentile; G Iannuzzo; S Panico; A Pujia; G M Bond; P Rubba
Journal:  Heart       Date:  2006-06-28       Impact factor: 5.994

3.  Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families.

Authors:  Ellen M Wijsman; Joseph H Rothstein; Robert P Igo; John D Brunzell; Arno G Motulsky; Gail P Jarvik
Journal:  Hum Genet       Date:  2010-04-11       Impact factor: 4.132

4.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Authors:  G M Dallinga-Thie; M van Linde-Sibenius Trip; J I Rotter; R M Cantor; X Bu; A J Lusis; T W de Bruin
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Authors:  B E Aouizerat; H Allayee; R M Cantor; R C Davis; C D Lanning; P Z Wen; G M Dallinga-Thie; T W de Bruin; J I Rotter; A J Lusis
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 6.  Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.

Authors:  M A Austin
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

7.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

8.  Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

Authors:  J E Hokanson; J D Brunzell; G P Jarvik; E M Wijsman; M A Austin
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

Authors:  H Allayee; B E Aouizerat; R M Cantor; G M Dallinga-Thie; R M Krauss; C D Lanning; J I Rotter; A J Lusis; T W de Bruin
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

10.  A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.

Authors:  S H Juo; S J Bredie; L A Kiemeney; P N Demacker; A F Stalenhoef
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.